Abstract:Dynamic cerebral blood flow (CBF) regulation via neurovascular coupling (NVC) is essential to meet localized brain oxygen and nutrient demands. Cerebral microvascular dysfunction contributes to the pathogenesis of many types of dementias. Previous studies suggest that oxidative stress play a critical role in endothelial disfunction, cerebral microvascular impairments, and blunted NVC responses. Increased reactive oxidative species (ROS), inflammatory cytokines, and decreased brain blood flow contribute to the progression of both vascular contributions to cognitive impairment and dementia (VCID) and Alzheimer's disease related dementia (ADRD).Our novel synthetic glycosylated Angiotensin-(1-7) derivative, PNA5, reverses cognitive deficits, inhibits brain ROS and inflammatory cytokine production, and limits microglial activation in our preclinical model of heart failure (HF)-induced VCID. We hypothesize that heart failure (HF) impairs cerebral vascular dilation and NVC, and that treatment with extended release PNA5 (PNA5ER) will improved cerebral vascular dilation and NVC. Adult male C57BL/6J mice (6-10/group) were subjected to HF via left anterior artery ligation or sham surgery 5 weeks prior to treatment with either 1) Vehicle (DMSO) or 2) 1.5mg PNA5ER (30uL of 50 mg/mL). Treatments were delivered subcutaneously at time= 3 weeks and again at t= 1 week prior to vascular evaluation and sacrifice. NVC was assessed using laser speckle imaging. Basal cerebral perfusion and NVC after somatosensory stimulation were assessed by laser speckle contrast imaging. NVC was calculated as a percent change in perfusion from baseline induced by stimulation. Basilar arteries were mounted on a wire myograph to assess cerebral vascular function. HF mice receiving vehicle treatment (n=2, mean= 4.41, Std Deviation=2.32) trend to have decreased NVC response compared to Sham (n=5, mean= 13.63, Std Deviation= 10.35), which may be rescued by PNA5ER (n=3, mean= 10.32, Std Deviation= 4.499). Endothelium-dependent dilation of basilar arteries, induced by cumulative concentrations of NS309 and 2-Methylthio-ADP, was impaired in HF compared to Sham mice; PNA5ER improved vasodilatory responses in the basilar artery.Our preliminary data suggest that PNA5ER protects against NVC impairments and improves basilar artery vasodilation in mice with HF-induced VCID, thereby potentially increasing the ability of the vasculature to meet the localized metabolic demands of the brain. Supported by NIA This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

NXP032 ameliorates cognitive impairment by alleviating the neurovascular aging process in aged mouse brain

Nicotinamide Phosphoribosyltransferase Inhibitor Ameliorates Mouse Aging-Induced Cognitive Impairment

NXP031 prevents dopaminergic neuronal loss and oxidative damage in the AAV-WT-α-synuclein mouse model of Parkinson's disease.

Treatment with the mitochondrial antioxidant peptide SS‐31 rescues neurovascular coupling responses and cerebrovascular endothelial function and improves cognition in aged mice

Nicotinamide mononucleotide (NMN) treatment attenuates oxidative stress and rescues angiogenic capacity in aged cerebromicrovascular endothelial cells: a potential mechanism for the prevention of vascular cognitive impairment

NAD+ rescues aging-induced blood-brain barrier damage via the CX43-PARP1 axis

NAD plus rescues aging-induced blood-brain barrier damage via the CX43-PARP1 axis

DL-3-n-butylphthalide imparts neuroprotection via Nrf2/SIRT3 pathway in a mouse model of vascular dementia

The combination of nicotinamide mononucleotide and lycopene prevents cognitive impairment and attenuates oxidative damage in D-galactose induced aging models via Keap1-Nrf2 signaling

Chronic β3 adrenergic agonist treatment improves brain microvascular endothelial function and cognition in aged mice

A novel therapeutic Ang(1-7) analogue improves neurovascular function in mice with vascular contributions to cognitive impairment and dementia

Treatment with the Mitochondrial‐targeted Antioxidant Peptide SS‐31 Improves Cerebromicrovascular Function in Aged Mice

The Protective Effect of Adiponectin-Transfected Endothelial Progenitor Cells on Cognitive Function in D-Galactose-Induced Aging Rats

SVHRSP Alleviates Age-Related Cognitive Deficiency by Reducing Oxidative Stress and Neuroinflammation

Neuronal mitochondria-targeted micelles relieving oxidative stress for delayed progression of Alzheimer's disease.

Co-treatment of Nicotinamide Mononucleotide and Neoagarooligosaccharide Mitigates Aging-Induced Cognitive Impairment by Promoting Mitochondrial Dynamics

Dl-3-n-Butylphthalide Improves Neuroinflammation in Mice with Repeated Cerebral Ischemia-Reperfusion Injury through the Nrf2-Mediated Antioxidant Response and TLR4/MyD88/NF-κB Signaling Pathway

Biocompatible polydopamine platform for targeting delivery of nicotinamide mononucleotide and boosting NAD+ level in brain

Novel, engineered fusogenic liposome-based anti-oxidant delivery system improves the blood-brain barrier integrity in aging

Euonymus alatus Leaf Extract Attenuates Effects of Aging on Oxidative Stress, Neuroinflammation, and Cognitive Impairment

Improving Mitochondrial Function for Alleviating Memory Decline of Aging Mice Via Dual-Delivering Lycopene Nanoparticles